BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32497403)

  • 1. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
    Oikonomopoulou C; Goussetis E
    Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
    Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
    J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
    Patel NC; Gallagher JL; Torgerson TR; Gilman AL
    J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
    Tsilifis C; Freeman AF; Gennery AR
    J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
    Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
    Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome.
    Harrison SC; Tsilifis C; Slatter MA; Nademi Z; Worth A; Veys P; Ponsford MJ; Jolles S; Al-Herz W; Flood T; Cant AJ; Doffinger R; Barcenas-Morales G; Carpenter B; Hough R; Haraldsson Á; Heimall J; Grimbacher B; Abinun M; Gennery AR
    J Clin Immunol; 2021 Jul; 41(5):934-943. PubMed ID: 33523338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A challenging differential diagnosis in a patient with autosomal dominant STAT3 deficiency.
    Bravo-Queipo-de-Llano B; Bonet D; Del Rosal T; Cámara C; Ruiz de Valbuena M; Pérez A; Grasa CD; Méndez-Echevarría A
    Pediatr Pulmonol; 2023 Feb; 58(2):585-591. PubMed ID: 36267002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper-IgE syndrome update.
    Sowerwine KJ; Holland SM; Freeman AF
    Ann N Y Acad Sci; 2012 Feb; 1250():25-32. PubMed ID: 22268731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations of hyper IgE syndromes.
    Freeman AF; Holland SM
    Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
    Paulson ML; Freeman AF; Holland SM
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care.
    Farmand S; Sundin M
    Curr Opin Hematol; 2015 Jan; 22(1):12-22. PubMed ID: 25469836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.
    Wolach O; Kuijpers T; Ben-Ari J; Gavrieli R; Feinstein-Goren N; Alders M; Garty BZ; Wolach B
    J Clin Immunol; 2014 Feb; 34(2):163-70. PubMed ID: 24452316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
    Alcántara-Montiel JC; Vega-Torres BI
    Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
    Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
    Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele-Specific Disruption of a Common
    König S; Fliegauf M; Rhiel M; Grimbacher B; Cornu TI; Cathomen T; Mussolino C
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Role of
    Moffitt K; Cheung E; Manis J; Malley R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.